This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2021 Feb;17(2):79-80.

doi: 10.1038/s41574-020-00452-3.

Metabolic liver disease - what's in a name?

Mark A Herman^{1

2}

Affiliations

Affiliations

¹ Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. mark.herman@duke.edu.
² Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA. mark.herman@duke.edu.

PMID: 33257823
DOI: 10.1038/s41574-020-00452-3

Review

Metabolic liver disease - what's in a name?

Mark A Herman. Nat Rev Endocrinol. 2021 Feb.

. 2021 Feb;17(2):79-80.

doi: 10.1038/s41574-020-00452-3.

Author

Mark A Herman^{1

2}

Affiliations

¹ Division of Endocrinology, Metabolism, and Nutrition, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. mark.herman@duke.edu.
² Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA. mark.herman@duke.edu.

PMID: 33257823
DOI: 10.1038/s41574-020-00452-3

No abstract available

PubMed Disclaimer

Similar articles

NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects.
Sliz E, Sebert S, Würtz P, Kangas AJ, Soininen P, Lehtimäki T, Kähönen M, Viikari J, Männikkö M, Ala-Korpela M, Raitakari OT, Kettunen J. Sliz E, et al. Hum Mol Genet. 2018 Jun 15;27(12):2214-2223. doi: 10.1093/hmg/ddy124. Hum Mol Genet. 2018. PMID: 29648650 Free PMC article.
How do genetic variants affect our interpretation of non-invasive tests for non-alcoholic fatty liver disease?
Lee HW, Ahn SH. Lee HW, et al. J Gastroenterol Hepatol. 2020 Jun;35(6):915-916. doi: 10.1111/jgh.15124. J Gastroenterol Hepatol. 2020. PMID: 32537755 No abstract available.
Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage.
Di Costanzo A, D'Erasmo L, Polimeni L, Baratta F, Coletta P, Di Martino M, Loffredo L, Perri L, Ceci F, Montali A, Girelli G, De Masi B, Angeloni A, Catalano C, Maranghi M, Del Ben M, Angelico F, Arca M. Di Costanzo A, et al. Atherosclerosis. 2017 Feb;257:232-239. doi: 10.1016/j.atherosclerosis.2016.12.018. Epub 2016 Dec 21. Atherosclerosis. 2017. PMID: 28027788
Intestinal Fructose and Glucose Metabolism in Health and Disease.
Merino B, Fernández-Díaz CM, Cózar-Castellano I, Perdomo G. Merino B, et al. Nutrients. 2019 Dec 29;12(1):94. doi: 10.3390/nu12010094. Nutrients. 2019. PMID: 31905727 Free PMC article. Review.
The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease.
Moore JB, Gunn PJ, Fielding BA. Moore JB, et al. Nutrients. 2014 Dec 10;6(12):5679-703. doi: 10.3390/nu6125679. Nutrients. 2014. PMID: 25514388 Free PMC article. Review.

See all similar articles

Cited by

A Systems Approach Dissociates Fructose-Induced Liver Triglyceride from Hypertriglyceridemia and Hyperinsulinemia in Male Mice.
Doridot L, Hannou SA, Krawczyk SA, Tong W, Kim MS, McElroy GS, Fowler AJ, Astapova II, Herman MA. Doridot L, et al. Nutrients. 2021 Oct 18;13(10):3642. doi: 10.3390/nu13103642. Nutrients. 2021. PMID: 34684643 Free PMC article.

References

1. Eslam, M. et al. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158, 1999–2014 (2020). - DOI
1. Younossi, Z. M. et al. From NAFLD to MAFLD: implications of a premature change in terminology. Hepatology https://doi.org/10.1002/hep.31420 (2020). - DOI - PubMed
1. Anstee, Q. M. et al. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort. J. Hepatol. 73, 505–515 (2020). - DOI
1. Zhu, C., Tabas, I., Schwabe, R. F. & Pajvani, U. B. Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis. Nat. Rev. Gastroenterol. Hepatol. https://doi.org/10.1038/s41575-020-00365-6 (2020). - DOI - PubMed
1. Haas, M. E. et al. Machine learning enables new insights into clinical significance of and genetic contributions to liver fat accumulation. Preprint at medRxiv https://doi.org/10.1101/2020.09.03.20187195 (2020). - DOI - PubMed - PMC

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

R01 DK100425/DK/NIDDK NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information